Don’t ever forget about the dividends. A couple months ago we were spiraling into a recession and bear market. Now, things look good. There’s a reason that dividends have accounted for 44% of market returns over the last hundred years.
Read More
This investment manager is trading at an undervalued level.
Read More
The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More
Cabot Weekly Review (Video)
In this week’s stock market video, Mike Cintolo discusses the continuing market uptrend, though isn't complacent when it comes to a couple of worries (some resistance, many stocks extended from good entry points, etc.). The key now is to focus some...
Read More
Cabot Weekly Review (Video)
In this week’s stock market video, Mike Cintolo discusses the continuing market uptrend, though isn't complacent when it comes to a couple of worries (some resistance, many stocks extended from good entry points, etc.). The key now is to focus some...
Read More
U.S. stocks continue to defy gravity, with their audacious 2019 year-to-date gains mirroring their equally extreme fourth quarter 2018 descent.
Read More
After dipping as low as $42, crude oil prices are back near $50 a barrel. These three oil ETFs are an efficient way to play the latest energy mini-rally.
Read More
From Cabot Top Ten Trader
The overall action from the major indexes and leading stocks remains about as good as you could hope for considering we’re two months off a major bottom—we’re nudging up our Market Monitor another notch (to 8) in this issue to the...
Read More
The worst monthly retail report in nine years did nothing to slow the momentum in retail stocks. But what does it mean for the sector going forward?
Read More
Big picture we remain very optimistic that the path of least resistance remains higher—the action of the market itself since the low, including the green light from the 2-to-1 Blastoff Indicator, looks like the initial thrust off a major low that should result higher...
Read More
Small caps keep grinding higher. And many of the stocks in our portfolio are trading at, or near, all-time highs.
Read More
It’s Not the News that Counts
One of the biggest banana peels that many investors slip up on is the desire to focus on the news, be it economic reports, high-profile earnings releases or important political rumors (like the current U.S.-China trade talks). But it...
Read More
Our Emerging Markets Timer is still positive and constructive, though the EEM was essentially flat during the last week.
Read More
Three stocks are updated due to Earnings Reports.
Read More
The simplest reason is an imbalance of supply and demand; if supply is insufficient to meet demand, as it often is in a brand new industry, prices rise. That’s one reason marijuana stocks have been rising, overall, for the past few years.
Read More
This list of the best investment sites to research stocks aims to help individual investors navigate the sea of stock-related information on the web.
Read More
This biopharma is expected to grow by 44.3% next year.
Read More
The market is stuck in an intermediate-term trading range, and could be for a while. But with no recession in sight, you should be buying stocks now.
Read More
Things could actually be turning optimistic for the market and it’s looking like this could be more than just a bounce back from the overdone December lows. There is still risk out there. But a catalyst may be emerging for strong upside with optimism...
Read More
One stock reports fourth-quarter results, another moves from Hold to Buy and we reiterate the Buy recommendation on a third.
Read More
